Clinical TrialsMirum’ Brelovitug Meets Phase 3 Endpoint in Chronic Hepatitis Delta Mirum’ Brelovitug Meets Phase 3 Endpoint in Chronic Hepatitis Delta Read Post »
New Drug ApprovalFDA Approves EMCITATE® (tiratricol), First Treatment for MCT8 Deficiency FDA Approves EMCITATE® (tiratricol), First Treatment for MCT8 Deficiency Read Post »
Clinical TrialsAscletis’ ASC50 Shows Sustained PASI Reduction, Supporting Longer-Duratio... Ascletis’ ASC50 Shows Sustained PASI Reduction, Supporting Longer-Duratio... Read Post »
Clinical TrialsDenifanstat Shows Sustained Efficacy Through 52 Weeks in Phase 3 Acne Exten... Denifanstat Shows Sustained Efficacy Through 52 Weeks in Phase 3 Acne Exten... Read Post »
Clinical TrialsZenkuda Meets DAYBREAK Endpoint With Sustained Six-Month Dosing in Wet AMD Zenkuda Meets DAYBREAK Endpoint With Sustained Six-Month Dosing in Wet AMD Read Post »
Clinical TrialsEvorpacept Shows Stronger Responses in HER2+ Gastric Cancer Evorpacept Shows Stronger Responses in HER2+ Gastric Cancer Read Post »
New Drug ApprovalFDA Approves WELIREG Plus LENVIMA for Advanced ccRCC FDA Approves WELIREG Plus LENVIMA for Advanced ccRCC Read Post »
Clinical TrialsVitamin K2 and D3 Slow Coronary Artery Calcification Progression in DANCODE... Vitamin K2 and D3 Slow Coronary Artery Calcification Progression in DANCODE... Read Post »
Clinical TrialsITM-11 Re-treatment Shows Promising Real-World Survival in SwissNet Analysi... ITM-11 Re-treatment Shows Promising Real-World Survival in SwissNet Analysi... Read Post »
New Drug ApprovalAbbVie’s Jumvo (Tavapadon) Receives FDA Approval for Parkinson’s Diseas... AbbVie’s Jumvo (Tavapadon) Receives FDA Approval for Parkinson’s Diseas... Read Post »
New Drug ApprovalFDA Approves Atebrioz (zilurgisertib) for FOP Treatment FDA Approves Atebrioz (zilurgisertib) for FOP Treatment Read Post »
New Drug ApprovalFDA Expands Olumiant Approval to Adolescents with Severe Alopecia Areata FDA Expands Olumiant Approval to Adolescents with Severe Alopecia Areata Read Post »
Clinical TrialsC4 Therapeutics Reports Biomarker Findings from Cemsidomide Studies in Mult... C4 Therapeutics Reports Biomarker Findings from Cemsidomide Studies in Mult... Read Post »
Clinical TrialsTREMFYA Improves Axial Psoriatic Arthritis Symptoms: STAR Study Results TREMFYA Improves Axial Psoriatic Arthritis Symptoms: STAR Study Results Read Post »
Clinical TrialsSura-vec Shows Three-Year DRSS Improvement in Diabetic Retinopathy Sura-vec Shows Three-Year DRSS Improvement in Diabetic Retinopathy Read Post »
Clinical TrialsGefurulimab Shows Sustained 52-Week Disease Control in Phase 3 PREVAIL Tria... Gefurulimab Shows Sustained 52-Week Disease Control in Phase 3 PREVAIL Tria... Read Post »
New Drug ApprovalFDA Approves Belzutifan Plus Lenvatinib for Advanced RCC With a Clear Cell ... FDA Approves Belzutifan Plus Lenvatinib for Advanced RCC With a Clear Cell ... Read Post »
Clinical TrialsCSPC’s Becotatug Plus Osimertinib Shows Positive Results in EGFR Exon 20 ... CSPC’s Becotatug Plus Osimertinib Shows Positive Results in EGFR Exon 20 ... Read Post »
Clinical TrialsKyverna Reports One-Year Data for Miv-cel in Stiff Person Syndrome and Gene... Kyverna Reports One-Year Data for Miv-cel in Stiff Person Syndrome and Gene... Read Post »
Clinical TrialsIMUNON IMNN-001 Shows 14.7-Month Survival Gain in Ovarian Cancer IMUNON IMNN-001 Shows 14.7-Month Survival Gain in Ovarian Cancer Read Post »
New Drug ApprovalLilly Wins FDA Approval for Once-Weekly Basal Insulin Onswik in Type 2 Diab... Lilly Wins FDA Approval for Once-Weekly Basal Insulin Onswik in Type 2 Diab... Read Post »
Clinical TrialsTECVAYLI Plus DARZALEX FASPRO Shows Sustained Survival Benefit in Early-Lin... TECVAYLI Plus DARZALEX FASPRO Shows Sustained Survival Benefit in Early-Lin... Read Post »
Clinical TrialsPDS0101 Plus Pembrolizumab Shows 39.3-Month Median Overall Survival in HPV1... PDS0101 Plus Pembrolizumab Shows 39.3-Month Median Overall Survival in HPV1... Read Post »
Clinical TrialsRoche’s Sefaxersen Cuts Proteinuria in Phase III IgA Nephropathy Study Roche’s Sefaxersen Cuts Proteinuria in Phase III IgA Nephropathy Study Read Post »
Drugs Safety AlertFDA Approves Boxed Warning for Adzynma Over Antibody Risk FDA Approves Boxed Warning for Adzynma Over Antibody Risk Read Post »
New Drug ApprovalFDA Approves Lyrfigtu for FGFR2-Positive Cholangiocarcinoma FDA Approves Lyrfigtu for FGFR2-Positive Cholangiocarcinoma Read Post »
Clinical TrialsORKA-001 Sustains Deep Psoriasis Clearance Through Week 28 After Two Doses ORKA-001 Sustains Deep Psoriasis Clearance Through Week 28 After Two Doses Read Post »
Clinical TrialsImmunovant Ends IMVT-1402 Development in Cutaneous Lupus After CLE Study Mi... Immunovant Ends IMVT-1402 Development in Cutaneous Lupus After CLE Study Mi... Read Post »
Clinical TrialsVarespladib Misses Phase 2 BRAVIO Primary Endpoints but Shows Signals in Kr... Varespladib Misses Phase 2 BRAVIO Primary Endpoints but Shows Signals in Kr... Read Post »
Clinical TrialsTegoprubart Shows Promising 24-Month Kidney Function Advantage Over Tacroli... Tegoprubart Shows Promising 24-Month Kidney Function Advantage Over Tacroli... Read Post »
Clinical TrialsViking’s VK2735 Maintains Most Weight Loss with Less Frequent Dosing Viking’s VK2735 Maintains Most Weight Loss with Less Frequent Dosing Read Post »
Clinical TrialsAmgen’s Dazodalibep Meets Phase 3 Endpoint in Sjögren’s Disease Amgen’s Dazodalibep Meets Phase 3 Endpoint in Sjögren’s Disease Read Post »
Clinical TrialsOtsuka Reports Positive Phase 3 FUSION Results in FUS-ALS Otsuka Reports Positive Phase 3 FUSION Results in FUS-ALS Read Post »
Clinical TrialsInaxaplin Reduces Proteinuria in Phase 2b AMPLIFIED AMKD Trial Inaxaplin Reduces Proteinuria in Phase 2b AMPLIFIED AMKD Trial Read Post »
Clinical TrialsFasedienol Shows Progressive Improvement in Social Anxiety During PALISADE-... Fasedienol Shows Progressive Improvement in Social Anxiety During PALISADE-... Read Post »
Clinical TrialsElunetirom Shows Positive Phase 2 Results in Bipolar Depression Elunetirom Shows Positive Phase 2 Results in Bipolar Depression Read Post »
Clinical TrialsRoche’s Enicepatide Shows Positive Results in Phase II T2D Trial Roche’s Enicepatide Shows Positive Results in Phase II T2D Trial Read Post »
New Drug ApprovalRINVOQ Gains EU Approval for Pediatric Polyarticular JIA RINVOQ Gains EU Approval for Pediatric Polyarticular JIA Read Post »
New Drug ApprovalRoche Susvimo Wins EU Approval for Neovascular AMD Roche Susvimo Wins EU Approval for Neovascular AMD Read Post »
Clinical TrialsBlinatumomab Replacing Chemotherapy Improves 4-Year Event-Free Survival in ... Blinatumomab Replacing Chemotherapy Improves 4-Year Event-Free Survival in ... Read Post »
Clinical TrialsRilzabrutinib Sustains Platelet Responses in LUNA3 ITP Study Rilzabrutinib Sustains Platelet Responses in LUNA3 ITP Study Read Post »
Clinical TrialsALKS 7290 Shows Dose-Dependent ADHD Symptom Improvements ALKS 7290 Shows Dose-Dependent ADHD Symptom Improvements Read Post »
Clinical TrialsCagriSema Shows Greater Weight Loss With Non-Inferior HbA1c Reduction CagriSema Shows Greater Weight Loss With Non-Inferior HbA1c Reduction Read Post »
Clinical TrialsCAPLYTA Shows Encouraging Results in Bipolar I Mania in New Study CAPLYTA Shows Encouraging Results in Bipolar I Mania in New Study Read Post »
Clinical TrialsTeva’s UZEDY Shows Real-World Benefits in Schizophrenia Teva’s UZEDY Shows Real-World Benefits in Schizophrenia Read Post »
Clinical TrialsAbbisko’s Lavengratinib Shows Early Growth Benefit in Children with A... Abbisko’s Lavengratinib Shows Early Growth Benefit in Children with A... Read Post »
Clinical TrialsTEV-‘749 Shows Durable Results in Phase 3 Schizophrenia Trial TEV-‘749 Shows Durable Results in Phase 3 Schizophrenia Trial Read Post »
Clinical TrialsHansoh’s HS-10374 Delivers Promising Phase 3 Results in Plaque Psoriasis Hansoh’s HS-10374 Delivers Promising Phase 3 Results in Plaque Psoriasis Read Post »
New Drug ApprovalFDA Grants Full Approval to Inluriyo Plus Verzenio for ESR1-Mutated Advance... FDA Grants Full Approval to Inluriyo Plus Verzenio for ESR1-Mutated Advance... Read Post »
New Drug ApprovalFDA Approves Aqneursa for Ataxia in Patients with Ataxia-Telangiectasia FDA Approves Aqneursa for Ataxia in Patients with Ataxia-Telangiectasia Read Post »
